RION Forms INTENT Biologics to Develop Clinical Exosome-Based Therapies
With the launch of INTENT Biologics, RION targets global impact in inflammation care; Suneet Varma named CEO to lead the charge.
Cerevel Therapeutics | 11/09/2025 | By Dineshwori
AbbVie Completes Acquisition of Cerevel Therapeutics
AbbVie has announced the completion of its acquisition of Cerevel Therapeutics.
Cerevel Therapeutics | 02/08/2024 | By Aishwarya | 318
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy